About Pivotal Therapeutics
Pivotal Therapeutics is a company based in Vaughan (Canada) founded in 2010 by George Jackowski and Rachelle MacSweeney.. Pivotal Therapeutics operates in a competitive market with competitors including Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others.
- Headquarter Vaughan, Canada
- Founders George Jackowski, Rachelle MacSweeney
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$7.7 M (USD), Debt – Conventional
Mar 04, 2014
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pivotal Therapeutics
- Total Funding Total Funding
- Total Rounds 1
- Last Round Debt – Conventional — $7.7M
-
First Round
First Round
(04 Mar 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2014 | Amount | Debt – Conventional - Pivotal Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Pivotal Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Pivotal Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pivotal Therapeutics Comparisons
Competitors of Pivotal Therapeutics
Pivotal Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for cardiovascular and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Innovative pharmaceuticals for cardiovascular and metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Pivotal Therapeutics
When was Pivotal Therapeutics founded?
Pivotal Therapeutics was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Where is Pivotal Therapeutics located?
Pivotal Therapeutics is headquartered in Vaughan, Canada. It is registered at Vaughan, Ontario, Canada.
Who is the current CEO of Pivotal Therapeutics?
Rachelle MacSweeney is the current CEO of Pivotal Therapeutics. They have also founded this company.
What does Pivotal Therapeutics do?
Pivotal Therapeutics is a Canadian, commercial-stage biopharma developing highly-purified prescription Omega 3 Therapy for CVD. In Feb 2016, it announced US patent for stabilization of vulnerable plaque using a combination of statin and Omega 3 fatty acids. The company has one prescription product and 2 OTC products. The prescription product is VASCAZEN, indicated for Omega-3 Deficiency in cardiovascular patients. The product was clinically shown to correct an Omega-3 Deficiency in CVD Patients, with an associated 48 reduction in triglycerides and a rise in HDL-C without negative impact on the LDL-C lipid profile in the 8-week treatment period. The 2 OTC Products are OMAZEN and BENEFISHIAL.
Who are the top competitors of Pivotal Therapeutics?
Pivotal Therapeutics's top competitors include Tenaya Therapeutics, Cellino and MyoKardia.